抗精神病药物暴露与痴呆风险之间的关联:一项针对415,100名参与者的前性队列研究
Li-Yun Ma1, Ya-Nan Ou1, Pei-Yang Gao1
1Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao 266071, China.
Journal of affective disorders
|January 10, 2024
概括
服用抗精神病药物会增加患痴呆症的风险,尤其是血管性痴呆症. 较高剂量的口服抗精神病药物显示了与痴呆风险的剂量反应关系.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 抗精神病药物 (APs) 被广泛处方,但与认知衰退有关.
- 之前关于AP和痴呆风险的研究是有限的和相互矛盾的.
研究的目的:
- 调查抗精神病药物暴露与痴呆风险之间的关联.
- 检查口服药物对痴呆症风险的剂量反应影响.
主要方法:
- 对415,100名英国生物库参与者的前性队列研究.
- 用于评估AP暴露和痴呆风险的多变量考克斯比例危险模型.
- 分析了口服AP的剂量反应关系.
主要成果:
- 抗精神病药物暴露增加了所有原因痴呆 (HR: 1.33) 和血管痴呆 (HR: 1.90) 的风险.
- 没有发现与阿尔茨海默病风险有显著关联 (HR:1.22).
- 在所有原因和血管痴呆症的口服AP中观察到的累积剂量反应关系.
结论:
- 抗精神病药物的使用与痴呆的风险增加有关.
- 口服抗精神病药物与痴呆症风险之间存在剂量依赖的关系.
- 提高医疗保健提供者和患者对这种风险的认识至关重要.
相关概念视频
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Psychosis and Antipsychotic Drugs: Overview
263
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
263
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
657
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
657
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
Psychological and Sociocultural Causes of Schizophrenia
90
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
90
Biological Causes of Schizophrenia
57
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
57


